In the media

<p>Image created by computer of a liver cancer (SEBASTIAN KAULITZKI/SCIENCE PHOT / Getty)</p>
13 Jan 2020 -

The Preguntas Big Van section of La Vanguardia has published an article on a new joint project being done by Raúl Méndez, group leader at the Institute for Research in Biomedicine (IRB Barcelona), together with Mercedes Fernández, researchers at the Instituto de Investigaciones Biomédicas August Pi i Sunyer.

This project seeks to analyse the cells that regulate the activity of genes (CPEB) during liver cancer development.  “We aim to unravel the mechanisms through which CPEBs contribute to tumour onset and growth,” explains Méndez. “If we understand these mechanisms then we might be able to develop pharmacological treatment to prevent or better treat liver cancer”.

This...

<p>The ICREA  researcher and head of Colorectal Cancer Lab.</p>
13 Jan 2020 -

La Razón has published an article about a study addressing the involvement of fibroblasts in colon cancer being carried out by "La Caixa" and the Colorectal Cancer Lab, headed by Eduard Batlle, ICREA researcher at the Institute for Research in Biomedicine (IRB Barcelona) and a CIBERONC member. 

Colon cancer is one of the most frequent types of cancer, and although treatment cures this disease for most patients, a large percentage develop metastases in vital organs.  In this regard, immunotherapy is not effective for this kind of cancer, benefiting only 5% of patients. This is because the colon cancer cells develop a mechanism through which to evade the immune system. “...

<p>Robert Soliva and Modesto Orozco with their team (César Rangel)</p>
8 Jan 2020 -

La Vanguardia has devoted an article to the Senén Vilaró Prize for the best innovative company, which has recently been awarded to Nostrum Biodiscovery (NBD). This prize acknowledges the capacity of the technology developed by this company to allow pharmaceutical companies to speed up drug discovery and reduce the costs involved.

NBD was founded in 2016 as a spin-off from the Institute for Research in Biomedicine (IRB Barcelona) and the Barcelona Supercomputing Center (BSC-CNS), with the objective to support the discovery and launch of new drugs and biotech molecules. Modesto Orozco, head of Molecullar Modelling and Bioinformatics lab and holder of an ERC Advanced Grant at IRB...

<p>Manuel Serrano, ICREA researcher at IRB Barcelona</p>
8 Jan 2020 -

Manuel Serrano, ICREA researcher at IRB Barcelona, participated in the programme Inmortals, broadcasted on TV3, in which he talked about aging. The slowing down of aging in mouse has been achieved.  It is now only a question of time until the resources are available to reverse aging and increase lifespan in humans.  In this regard, Serrano says, “I don’t know whether the limit will be 120 or 140 years, but I am sure lifespan will increase"

 

Link to TV3

<p>Eduard Batlle (right) with Daniel Tauriello, at IRB Barcelona (Llibert Teixidó)</p>
8 Jan 2020 - La Vanguardia

The “Preguntas Big Van” section of the newspaper La Vanguardia interviewed Eduard Batlle, ICREA researcher and head of the Colorectal Cancer Lab at IRB Barcelona, about his collaboration with the Centro de Análisis Genómico regarding the study of colorectal tumour samples using the new unicellular analysis method. “This technique allows us to see what is happening inside the tumour at a level of detail that was unimaginable 5 years ago,” says Batlle. His objective is “to develop efficient therapies for patients with advanced colorectal cancer, which may also be useful for treating the metastasis of other types of tumour,” explains the researcher.

 

Link to:...

<p>ICREA researcher at IRB Barcelona, Núria López-Bigas</p>
23 Dec 2019 -

The newspaper La Vanguardia has reported on the award of the “Doctores Diz Pintado” National Cancer Research Prize, to  Núria López-Bigas ICREA researcher at the Institute for Research in Biomedicine (IRB Barcelona)  in recognition of her work on the accumulation of mutations in the genome. Referring to López-Bigas, the jury highlighted "the relevance and impact of her work, which focuses on genomics and has wide applications in personalised medicine."

Link to: La Vanguardia 

 

<p>Modesto Orozco, head of the Molecular Modelling and Bioinformatics Lab at IRB Barcelona</p>
19 Dec 2019 -

Nostrum Biodiscovery, a company founded by Modesto Orozco, head of the Molecular Modelling and Bioinformatics Lab at IRB Barcelona, features in an article published by Expansión and devoted to the Botín Foundation’s "Mind the Gap" Programme.

<p>Roger Gomis, head of the Growth Control and Metastasis Laboratory, IRB Barcelona.</p>
29 Nov 2019 -

The newspaper ABC has reported on a new project to be launched by IRB Barcelona researcher Roger Gomis thanks to a grant from the Fundación Fero y Mango. Focusing on luminal breast cancer, one of the most common subtypes, the project aims to decipher the “dialogue” between tumour cells and bone stem cells. This information can then be used to design therapeutic targets and to limit the capacity of these cells to metastasize. “This is a groundbreaking approach to tackle metastasis in this kind of cancer,” says Gomis.

Beside, La Razón has reported on this project. In its article “Visionarios contra el cáncer”, it highlights that 15% of women with this type of tumour experience...

<p>Meritxell Teixidó, IRB Barcelona</p>
27 Nov 2019 -

In its “Preguntas Big Van” section, the newspaper La Vanguardia has interviewed IRB Barcelona researcher Meritxell Teixidó about her project, which seeks to develop “shuttles” that transport drugs into the brain. In this regard, 98% of drugs that start to be developed to treat diseases of the central nervous system are abandoned because they cannot cross the barrier that protects the brain. Inspired on bee and scorpion venom, Teixidó has identified several families of peptides capable of crossing this barrier. The research has been possible thanks to the funding of a CaixaImpulse project from the ”la Caixa” Foundation and a project awarded through the La Fundació La Marató de TV3.

...
<p>Manuel Serrano, ICREA researcher at IRB Barcelona, during his talk at the Barcelona Biomed Conference.</p>
27 Nov 2019 -

The newspapers El País and ABC, among other media, have echoed on the last Barcelona Biomed Conference, called “Immunotherapy beyond cancer. A cure for age-related diseases”, which was held from 18 to 20 November.  “Immunotherapy is still very experimental, but we believe that in the future it could be beneficial for the treatment of diseases such as Alzheimer’s, Parkinson’s and pulmonary and renal fibrosis,” says Manuel Serrano, ICREA researcher at IRB Barcelona and co-organiser of the conference together with the scientist Guido Kroemer, from the Centre de Recherche des Cordeliers (Paris). As in previous events, this conference was organised by IRB Barcelona with the support of the...